Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.
Kathleen L RuchalskiHyun J KimMichael DouekSteven RamanMaitraya PatelVictor SaiAntonio GutierrezBenjamin LevineCheryce FischerMartin Allen-AuerbachPawan GuptaHeidi CoyBianca VillegasMatthew BrownJonathan GoldinPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2022)
Patients with pre-treatment visceral metastases in mCRPC are more likely to experience disease progression of bone disease with the initial anatomic site of progression similar to those without baseline visceral involvement.